Table: Kubota Pharmaceutical Holdings -2019 group results (IFRS)

Kubota Pharmaceutical Holdings

13/02/2020 06:00

Feb 13 (Reuters)- 
              Kubota Pharmaceutical Holdings Co., Ltd. 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   Year ended      Year ended        Year to         NEXT  
                Dec 31, 2019    Dec 31, 2018    Dec 31, 2020       YEAR    
                   LATEST         YEAR-AGO         COMPANY       COMPANY   
                   RESULTS         RESULT         FORECAST     H1 FORECAST 
  Sales             0 mln           0 mln                                  
  Operating       loss 3.32       loss 3.27       loss 2.50                
  Pretax          loss 3.14       loss 3.05       loss 2.40                
  Net             loss 3.10       loss 3.05       loss 2.40                
  EPS Basic    loss 73.85 yen  loss 78.42 yen  loss 56.73 yen              
  EPS Diluted  loss 73.85 yen  loss 78.42 yen                              
  Ann Div            NIL             NIL             NIL                   
  -Q2 Div            NIL             NIL             NIL                   
  -Q4 Div            NIL             NIL             NIL                   
 
  NOTE - Kubota Pharmaceutical Holdings Co., Ltd.. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company.
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4596.T